P A Marks

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

Lisa M. Butler, David B. Agus, Howard I. Scher et al. · PubMed · 2000 · 617 citations

Medicine, Oncology, Pharmacology +13

Histone deacetylase (HDAC) inhibitor activation of p21 ^WAF1 involves changes in promoter-associated proteins, including HDAC1

C. Gui, Lang Ngo, Weili Xu et al. · Proceedings of the National Academy of Sciences · 2004 · 554 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

Johanna Ungerstedt, Yoshihiro Sowa, Weili Xu et al. · Proceedings of the National Academy of Sciences · 2005 · 507 citations · Full text

Medicine, Oncology, Pharmacology +6

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Victoria M. Richon, Yael Webb, R Merger et al. · Proceedings of the National Academy of Sciences · 1996 · 421 citations

Medicine, Oncology, Pharmacology +13

Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.

Hiroshi Yamasaki, Eitan Fibach, Uri Nudel et al. · Proceedings of the National Academy of Sciences · 1977 · 234 citations · Full text

Medicine, Oncology, Pharmacology +10